Mali - Women's share of population ages 15+ living with HIV (%)

Women's share of population ages 15+ living with HIV (%) in Mali was 61.50 as of 2020. Its highest value over the past 30 years was 61.50 in 2020, while its lowest value was 53.50 in 1990.

Definition: Prevalence of HIV is the percentage of people who are infected with HIV. Female rate is as a percentage of the total population ages 15+ who are living with HIV.

Source: UNAIDS estimates.

See also:

Year Value
1990 53.50
1991 54.20
1992 54.80
1993 55.30
1994 55.70
1995 56.10
1996 56.40
1997 56.80
1998 57.10
1999 57.40
2000 57.60
2001 57.90
2002 58.10
2003 58.30
2004 58.40
2005 58.50
2006 58.50
2007 58.50
2008 58.60
2009 58.60
2010 58.60
2011 58.60
2012 58.90
2013 59.20
2014 59.60
2015 60.00
2016 60.40
2017 60.70
2018 60.90
2019 61.20
2020 61.50

Limitations and Exceptions: The limited availability of data on health status is a major constraint in assessing the health situation in developing countries. Surveillance data are lacking for many major public health concerns. Estimates of prevalence and incidence are available for some diseases but are often unreliable and incomplete. National health authorities differ widely in capacity and willingness to collect or report information.

Statistical Concept and Methodology: HIV prevalence rates reflect the rate of HIV infection in each country's population. Low national prevalence rates can be misleading, however. They often disguise epidemics that are initially concentrated in certain localities or population groups and threaten to spill over into the wider population. In many developing countries most new infections occur in young adults, with young women especially vulnerable. Data on HIV are from the Joint United Nations Programme on HIV/AIDS (UNAIDS). Changes in procedures and assumptions for estimating the data and better coordination with countries have resulted in improved estimates of HIV and AIDS. The models, which are routinely updated, track the course of HIV epidemics and their impact, making full use of information in HIV prevalence trends from surveillance data as well as survey data. The models take into account reduced infectivity among people receiving antiretroviral therapy (which is having a larger impact on HIV prevalence and allowing HIV-positive people to live longer) and allow for changes in urbanization over time in generalized epidemics. The estimates include plausibility bounds, which reflect the certainty associated with each of the estimates.

Aggregation method: Weighted average

Periodicity: Annual

Classification

Topic: Health Indicators

Sub-Topic: Risk factors